In the first part, hosted by Irene Ghobrial, MD, Professor of Medicine, DanaFarber Cancer Institute, Boston, Massachusetts, we discuss an overview of multiple myeloma precursor conditions.

In the second part (24:05), hosted by Omar Nadeem, MD, Instructor in Medicine, Harvard Medical School, Clinical Director, Myeloma Immune Effector Cell Therapy Program, DanaFarber Cancer Institute, Boston, Massachusetts, we discuss therapeutic intervention in precursor plasma cell disorders.

The Multiple Myeloma Research Foundation (MMRF) drives discoveries for new treatments, accelerates groundbreaking clinical trials and fuels the most robust datadriven initiatives in cancer research. Our goal is to find a cure for each and every patient diagnosed with multiple myeloma. Learn more about us at https://themmrf.org/.